Mytrex Health Technologies, Inc. (TPEX:4431)

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Medicine Distribution Division	1.77B	1.59B	1.11B	-	-
Technological Material Business Segment	129.71M	109.80M	134.77M	192.23M	260.47M
Medical Biotechnology Business Sector (Including Medical Sanitation Materials)	49.77M	53.33M	41.23M	42.58M	40.38M
Other Department	11.00K	2.98M	4.33M	-	636.00K
Adjustment and Elimination	-19.00K	-29.00K	-	-1.73M	-9.19M
Medical Sanitation Materials	-	-	-	1.24B	-
Total	1.94B	1.76B	1.29B	1.47B	292.29M

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Asia	1.92B	1.75B	1.27B	1.45B	273.77M
Europe	4.28M	10.89M	20.94M	5.13M	12.69M
Other countries	16.38M	392.00K	1.72M	19.00M	2.44M
America	-	-	-	-	2.72M
Total	1.94B	1.76B	1.29B	1.47B	291.62M

Data Source: S&P Global Market Intelligence Last updated: Dec 31, 2025

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Jul 28, 2026

Data Sources Report a data error